Self Injection Device Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Self Injection Device market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Self Injection Device market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Self Injection Device market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Self Injection Device market segmented into
- Reusable Self Injection Device
- Disposable Self Injection Device
- Insulin Injection
- Epinephrine Injection
- Others
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Novo Nordisk
- Mylan
- Pfizer
- Sanofi
- BD
- Eli Lilly
- Gerresheimer
- Dongbao
- Ypsomed
- Owen Mumford
- Antares Pharma
- Haselmeier
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL SELF INJECTION DEVICE INDUSTRY
2.1 Summary about Self Injection Device Industry
2.2 Self Injection Device Market Trends
2.2.1 Self Injection Device Production & Consumption Trends
2.2.2 Self Injection Device Demand Structure Trends
2.3 Self Injection Device Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Reusable Self Injection Device
4.2.2 Disposable Self Injection Device
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Insulin Injection
4.3.2 Epinephrine Injection
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Reusable Self Injection Device
5.2.2 Disposable Self Injection Device
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Insulin Injection
5.3.2 Epinephrine Injection
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Reusable Self Injection Device
6.2.2 Disposable Self Injection Device
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Insulin Injection
6.3.2 Epinephrine Injection
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Reusable Self Injection Device
7.2.2 Disposable Self Injection Device
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Insulin Injection
7.3.2 Epinephrine Injection
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Reusable Self Injection Device
8.2.2 Disposable Self Injection Device
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Insulin Injection
8.3.2 Epinephrine Injection
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Reusable Self Injection Device
9.2.2 Disposable Self Injection Device
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Insulin Injection
9.3.2 Epinephrine Injection
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Novo Nordisk
10.1.2 Mylan
10.1.3 Pfizer
10.1.4 Sanofi
10.1.5 BD
10.1.6 Eli Lilly
10.1.7 Gerresheimer
10.1.8 Dongbao
10.1.9 Ypsomed
10.1.10 Owen Mumford
10.1.11 Antares Pharma
10.1.12 Haselmeier
10.2 Self Injection Device Sales Date of Major Players (2017-2020e)
10.2.1 Novo Nordisk
10.2.2 Mylan
10.2.3 Pfizer
10.2.4 Sanofi
10.2.5 BD
10.2.6 Eli Lilly
10.2.7 Gerresheimer
10.2.8 Dongbao
10.2.9 Ypsomed
10.2.10 Owen Mumford
10.2.11 Antares Pharma
10.2.12 Haselmeier
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL SELF INJECTION DEVICE INDUSTRY
2.1 Summary about Self Injection Device Industry
2.2 Self Injection Device Market Trends
2.2.1 Self Injection Device Production & Consumption Trends
2.2.2 Self Injection Device Demand Structure Trends
2.3 Self Injection Device Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Reusable Self Injection Device
4.2.2 Disposable Self Injection Device
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Insulin Injection
4.3.2 Epinephrine Injection
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Reusable Self Injection Device
5.2.2 Disposable Self Injection Device
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Insulin Injection
5.3.2 Epinephrine Injection
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Reusable Self Injection Device
6.2.2 Disposable Self Injection Device
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Insulin Injection
6.3.2 Epinephrine Injection
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Reusable Self Injection Device
7.2.2 Disposable Self Injection Device
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Insulin Injection
7.3.2 Epinephrine Injection
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Reusable Self Injection Device
8.2.2 Disposable Self Injection Device
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Insulin Injection
8.3.2 Epinephrine Injection
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Reusable Self Injection Device
9.2.2 Disposable Self Injection Device
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Insulin Injection
9.3.2 Epinephrine Injection
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Novo Nordisk
10.1.2 Mylan
10.1.3 Pfizer
10.1.4 Sanofi
10.1.5 BD
10.1.6 Eli Lilly
10.1.7 Gerresheimer
10.1.8 Dongbao
10.1.9 Ypsomed
10.1.10 Owen Mumford
10.1.11 Antares Pharma
10.1.12 Haselmeier
10.2 Self Injection Device Sales Date of Major Players (2017-2020e)
10.2.1 Novo Nordisk
10.2.2 Mylan
10.2.3 Pfizer
10.2.4 Sanofi
10.2.5 BD
10.2.6 Eli Lilly
10.2.7 Gerresheimer
10.2.8 Dongbao
10.2.9 Ypsomed
10.2.10 Owen Mumford
10.2.11 Antares Pharma
10.2.12 Haselmeier
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Self Injection Device Product Type Overview
2.Table Self Injection Device Product Type Market Share List
3.Table Self Injection Device Product Type of Major Players
4.Table Brief Introduction of Novo Nordisk
5.Table Brief Introduction of Mylan
6.Table Brief Introduction of Pfizer
7.Table Brief Introduction of Sanofi
8.Table Brief Introduction of BD
9.Table Brief Introduction of Eli Lilly
10.Table Brief Introduction of Gerresheimer
11.Table Brief Introduction of Dongbao
12.Table Brief Introduction of Ypsomed
13.Table Brief Introduction of Owen Mumford
14.Table Brief Introduction of Antares Pharma
15.Table Brief Introduction of Haselmeier
16.Table Products & Services of Novo Nordisk
17.Table Products & Services of Mylan
18.Table Products & Services of Pfizer
19.Table Products & Services of Sanofi
20.Table Products & Services of BD
21.Table Products & Services of Eli Lilly
22.Table Products & Services of Gerresheimer
23.Table Products & Services of Dongbao
24.Table Products & Services of Ypsomed
25.Table Products & Services of Owen Mumford
26.Table Products & Services of Antares Pharma
27.Table Products & Services of Haselmeier
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Self Injection Device Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Self Injection Device Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Self Injection Device Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Self Injection Device Market Forecast (Million USD) Share by Demand 2021f-2026f
1.Table Self Injection Device Product Type Overview
2.Table Self Injection Device Product Type Market Share List
3.Table Self Injection Device Product Type of Major Players
4.Table Brief Introduction of Novo Nordisk
5.Table Brief Introduction of Mylan
6.Table Brief Introduction of Pfizer
7.Table Brief Introduction of Sanofi
8.Table Brief Introduction of BD
9.Table Brief Introduction of Eli Lilly
10.Table Brief Introduction of Gerresheimer
11.Table Brief Introduction of Dongbao
12.Table Brief Introduction of Ypsomed
13.Table Brief Introduction of Owen Mumford
14.Table Brief Introduction of Antares Pharma
15.Table Brief Introduction of Haselmeier
16.Table Products & Services of Novo Nordisk
17.Table Products & Services of Mylan
18.Table Products & Services of Pfizer
19.Table Products & Services of Sanofi
20.Table Products & Services of BD
21.Table Products & Services of Eli Lilly
22.Table Products & Services of Gerresheimer
23.Table Products & Services of Dongbao
24.Table Products & Services of Ypsomed
25.Table Products & Services of Owen Mumford
26.Table Products & Services of Antares Pharma
27.Table Products & Services of Haselmeier
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Self Injection Device Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Self Injection Device Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Self Injection Device Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Self Injection Device Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Self Injection Device Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Self Injection Device Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Self Injection Device Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Self Injection Device Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Self Injection Device Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Self Injection Device Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Self Injection Device Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Reusable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Disposable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Insulin Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Epinephrine Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Reusable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Disposable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Insulin Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Epinephrine Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Reusable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Disposable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Insulin Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Epinephrine Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Reusable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Disposable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Insulin Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Epinephrine Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Reusable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Disposable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Insulin Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Epinephrine Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Reusable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Disposable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Insulin Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Epinephrine Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Self Injection Device Sales Revenue (Million USD) of Novo Nordisk 2017-2020e
66.Figure Self Injection Device Sales Revenue (Million USD) of Mylan 2017-2020e
67.Figure Self Injection Device Sales Revenue (Million USD) of Pfizer 2017-2020e
68.Figure Self Injection Device Sales Revenue (Million USD) of Sanofi 2017-2020e
69.Figure Self Injection Device Sales Revenue (Million USD) of BD 2017-2020e
70.Figure Self Injection Device Sales Revenue (Million USD) of Eli Lilly 2017-2020e
71.Figure Self Injection Device Sales Revenue (Million USD) of Gerresheimer 2017-2020e
72.Figure Self Injection Device Sales Revenue (Million USD) of Dongbao 2017-2020e
73.Figure Self Injection Device Sales Revenue (Million USD) of Ypsomed 2017-2020e
74.Figure Self Injection Device Sales Revenue (Million USD) of Owen Mumford 2017-2020e
75.Figure Self Injection Device Sales Revenue (Million USD) of Antares Pharma 2017-2020e
76.Figure Self Injection D
1.Figure Global Self Injection Device Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Self Injection Device Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Self Injection Device Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Self Injection Device Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Self Injection Device Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Self Injection Device Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Self Injection Device Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Reusable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Disposable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Insulin Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Epinephrine Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Reusable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Disposable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Insulin Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Epinephrine Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Reusable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Disposable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Insulin Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Epinephrine Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Reusable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Disposable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Insulin Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Epinephrine Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Reusable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Disposable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Insulin Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Epinephrine Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Reusable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Disposable Self Injection Device Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Insulin Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Epinephrine Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Self Injection Device Sales Revenue (Million USD) of Novo Nordisk 2017-2020e
66.Figure Self Injection Device Sales Revenue (Million USD) of Mylan 2017-2020e
67.Figure Self Injection Device Sales Revenue (Million USD) of Pfizer 2017-2020e
68.Figure Self Injection Device Sales Revenue (Million USD) of Sanofi 2017-2020e
69.Figure Self Injection Device Sales Revenue (Million USD) of BD 2017-2020e
70.Figure Self Injection Device Sales Revenue (Million USD) of Eli Lilly 2017-2020e
71.Figure Self Injection Device Sales Revenue (Million USD) of Gerresheimer 2017-2020e
72.Figure Self Injection Device Sales Revenue (Million USD) of Dongbao 2017-2020e
73.Figure Self Injection Device Sales Revenue (Million USD) of Ypsomed 2017-2020e
74.Figure Self Injection Device Sales Revenue (Million USD) of Owen Mumford 2017-2020e
75.Figure Self Injection Device Sales Revenue (Million USD) of Antares Pharma 2017-2020e
76.Figure Self Injection D
